Tags » Cochrane Review
Estriol and Vitamin D are being tested on MS patients. Do you foresee significant changes to the treatment of MS within the next five to 10 years?
Saddled with an inappropriate, poorly predictive animal model and relatively sparse basic research on human MS (multiple sclerosis) lesions, antigenic targets of anti-human MS T and B cell responses remain poorly identified. 1,429 more words